One major mechanism is that adiponectin can decrease blood insulin levels [5,33–35], and therefore can inhibit cancer development, as the insulin-upregulated estrogen is one of the predominant risk factor for endometrial cancer [13,20,32,36,37]. Here, INS is linked to endometrial cancer.